Professor Sir Rory Collins
Colleges
Websites
-
UK Biobank
Principal Investigator and Chief Execuitve
-
British Heart Foundation
Professor of Medicine and Epidemiology
-
Tokai University
Adjunctive Professor
-
China Oxford Centre for International Health Research
Honorary Director
-
Beijing Union Medical College and Chinese Academy of Medical Sciences
Honorary Professor
Rory Collins
FRS, FMedSci
Head of Nuffield Department of Population Health and BHF Professor of Medicine and Epidemiology
Rory Collins studied Medicine at St Thomas’s Hospital Medical School, London University (1974-1980), and Statistics at George Washington University (1976-7) and at Oxford University (1982-3).
In 1985 he became co-director, with Professor Sir Richard Peto, of the University of Oxford's Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU). In 1996, he was appointed Professor of Medicine and Epidemiology at Oxford, supported by the British Heart Foundation.
He became Principal Investigator and Chief Executive of the UK Biobank prospective study of 500,000 people in September 2005. From July 2013, he became the Head of the Nuffield Department of Population Health at Oxford University.
His work has been in the establishment of large-scale epidemiological studies of the causes, prevention and treatment of heart attacks, other vascular disease, and cancer. He was knighted in 2011 for his services to science.
Key publications
-
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
Journal article
Baigent C. et al, (2005), Lancet, 366, 1267 - 1278
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
Journal article
Antithrombotic Trialists' Collaboration None., (2002), BMJ, 324, 71 - 86
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
Journal article
Heart Protection Study Collaborative Group None., (2002), Lancet, 360, 7 - 22
Recent publications
-
Long-term exposure to fine particulate matter and incidence of esophageal cancer: a prospective study of 0.5 million Chinese adults.
Journal article
Sun D. et al, (2023), Gastroenterology
-
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
Journal article
PARISH S. et al, (2023), Trials
-
Diabetes and infectious disease mortality in Mexico City
Journal article
EMBERSON J. et al, (2023), BMJ Open Diabetes Research and Care
-
Mechanisms and Predictors of Acute Kidney Injury with Perioperative Rosuvastatin in Patients Undergoing Cardiac Surgery
Preprint
Wijesurendra RS. et al, (2023)
-
Genetically Predicted Differences in Systolic Blood Pressure and Risk of Cardiovascular and Noncardiovascular Diseases: A Mendelian Randomization Study in Chinese Adults.
Journal article
Clarke R. et al, (2023), Hypertension (Dallas, Tex. : 1979)